Health
Research reveals underperformance of many Phase III oncology trials – News-Medical.Net
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than…
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than 80% of therapies tested in Phase III oncology trials did not achieve meaningful clinical benefit in prolonging survival. The researchers…
Continue Reading
-
Noosa News24 hours agoAI a ‘strategic necessity’ law lecturer says – Proctor
-
Noosa News23 hours agoMystery surrounding identity of young man found dead in Toohey Forest sparks public appeal
-
General18 hours agoEmbrace AI or risk future ruin, tech billionaire warns
-
Noosa News23 hours agoRoom-naming honour for rights champion – Proctor